Inventor · disambiguated record
Meredeth A. Mcgowan
Also filed as: MCGOWAN MEREDETH · MCGOWAN MEREDETH A · MCGOWAN MEREDETH ANN
18 granted patents·1 pending application·5 citations·filing 2013–2025
86Inventor score
Top patents by PatentIndex Score
19 records- 0181US10995085B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted May 4, 2021·1 cites·12 claims
- 0273US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 0363US10647705B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 12, 2020·0 cites·16 claims
- 0463US10100064B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·1 cites·11 claims
- 0556US12454525B2IL4I1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 28, 2025·0 cites·25 claims
- 0653US12157727B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 3, 2024·0 cites·20 claims
- 0751US11179389B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2018·Granted Nov 23, 2021·0 cites·13 claims
- 0849US11103493B2Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Aug 31, 2021·0 cites·18 claims
- 0948US11111232B2Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 1047US11208407B2Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·16 claims
- 1146US11319283B2Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 3, 2022·0 cites·7 claims
- 1245US11319295B2Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 3, 2022·0 cites·15 claims
- 1345US2025346600A1Tricyclic derivatives and related usesMOMA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1443US11230547B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2018·Granted Jan 25, 2022·0 cites·3 claims
- 1543US11096930B2Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenaseIOMET PHARMA LTD·Filed 2017·Granted Aug 24, 2021·0 cites·14 claims
- 1641US9938281B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·0 cites·18 claims
- 1739US10538497B2Compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 21, 2020·0 cites·19 claims
- 1837US10501458B2Substituted bicyclic fused ring compounds as indoleamine-2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 10, 2019·0 cites·9 claims
- 1934US10221178B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →